#  eye Insights 17: Fuchs Dystrophy 

 



 ##  

  expand\_more  

 
  

 

 Fu

   ![Eye Insights 17 Cover](/sites/g/files/omnuum9886/files/styles/hwp_1_1__100x100_scale/public/eye/files/ei_18_cover.jpg?itok=Eq6V9PQl) 

 

chs endothelial corneal dystrophy is a progressive disease that affects about 4% of adults worldwide and, if left untreated, can lead to corneal edema and painful loss of vision. Inside this issue of Eye Insights, you will find helpful information for identifying the disease and advising your patients on next steps for treatment. **Inside**

 • Risk factors  
• Diagnosis & treatment  
• Latest advances

 *Editor-in-Chief: Joan W. Miller, MD  
Managing Editor: Matthew F. Gardiner, MD  
Publications Editor: Jessica O'Donnell  
Clinical Advisory Group: Deeba Husain, MD, Alice Lorch, MD, MPH, Ankoor Shah, MD, PhD  
Contributor: Ula V. Jurkunas, MD  
Design: Stone Design Studio*

 [Browse all issues &gt; &gt;](/documents/newsletter/eye-insights) | Email: <eyeinsights@meei.harvard.edu>

 [Eye Insights 17: Fuchs Dystrophy](/file_url/3135)



 



 

 See also:- [ eye Insights ](/newsletter/eye-insights)